Page 128 - 中国全科医学2022-11
P. 128

http://www.chinagp.net   E-mail:zgqkyx@chinagp.net.cn  ·1405·


               follow-up of a randomized controlled trial[J]. Clin Rehabil,  Gait Posture,2013,38(3):403-409. DOI:10.1016/j.
               2019,33(1):24-33. DOI:10.1177/0269215518788598.      gaitpost.2013.01.006.
           [55]KINNE B L,OWENS K J,RAJALA B A,et al. Effectiveness of   [63]ROBINSON B S,COOK J L,RICHBURG C M,et al. Use of
               home-based virtual reality on vestibular rehabilitation outcomes:a   an electrotactile vestibular substitution system to facilitate balance
               systematic review[J]. Physical Therapy Reviews,2019,24(6):  and gait of an individual with gentamicin-induced bilateral
               280-290. DOI:10.1080/10833196.2019.1647382.          vestibular hypofunction and bilateral transtibial amputation[J].
           [56]ASAI  T,DOI  T,HIRATA  S,et  al.  Dual  tasking  affects   J  Neurol  Phys  Ther,2009,33(3):150-159.  DOI:
               lateral trunk control in healthy younger and older adults[J].   10.1097/npt.0b013e3181a79373.
               Gait Posture,2013,38(4):830-836. DOI:10.1016/j.  [64]VUILLERME N,HLAVACKOVA P,FRANCO C,et al. Can an
               gaitpost.2013.04.005.                                electro-tactile vestibular substitution system improve balance in
           [57]ASAI T,MISU S,DOI T,et al. Effects of dual-tasking on control   patients with unilateral vestibular loss under altered somatosensory
               of trunk movement during gait:respective effect of manual-and   conditions from the foot and ankle ?[J]. Annu Int Conf
               cognitive-task[J]. Gait Posture,2014,39(1):54-59.    IEEE Eng Med Biol Soc,2011,2011:1323-1326. DOI:
               DOI:10.1016/j.gaitpost.2013.05.025.                  10.1109/iembs.2011.6090311.
           [58]BERNARD-DEMANZE L,DUMITRESCU M,JIMENO P,et al.   [65]BITTAR R S,BARROS CDE G. Vestibular rehabilitation with
               Age-related changes in posture control are differentially affected   biofeedback in patients with central imbalance[J]. Braz J
               by postural and cognitive task complexity[J]. Curr Aging Sci,  Otorhinolaryngol,2011,77(3):356-361. DOI:10.1590/
               2009,2(2):135-149. DOI:10.2174/1874609810902020135.   s1808-86942011000300014.
           [59]HWANG  J  H,LEE  C  H,CHANG  H  J,et  al.  Sequential   [66]GABILAN Y P,PERRACINI M R,MUNHOZ M S,et al. Aquatic
               analysis of postural control resource allocation during a dual task   physiotherapy for vestibular rehabilitation in patients with unilateral
               test[J]. Ann Rehabil Med,2013,37(3):347-354. DOI:    vestibular hypofunction:exploratory prospective study[J].
               10.5535/arm.2013.37.3.347.                           J Vestib Res,2008,18(2/3):139-146.
           [60]HYNDMAN D,ASHBURN A. Stops walking when talking as a   [67]CHEN E W,FU A S,CHAN K M,et al. The effects of Tai Chi
               predictor of falls in people with stroke living in the community[J].   on the balance control of elderly persons with visual impairment:
               J Neurol Neurosurg Psychiatry,2004,75(7):994-997. DOI:  a randomised clinical trial[J]. Age Ageing,2012,41(2):
               10.1136/jnnp.2003.016014.                            254-259. DOI:10.1093/ageing/afr146.
           [61]NORDIN  E,MOE-NILSSEN  R,RAMNEMARK  A,et  al.   [68]TSANG W W,HUI-CHAN C W. Standing balance after vestibular
               Changes in step-width during dual-task walking predicts falls[J].   stimulation in Tai Chi-practicing and nonpracticing healthy older
               Gait  Posture,2010,32(1):92-97.  DOI:10.1016/j.      adults[J]. Arch Phys Med Rehabil,2006,87(4):546-553.
               gaitpost.2010.03.012.                                DOI:10.1016/j.apmr.2005.12.040.
           [62]RAO A K,UDDIN J,GILLMAN A,et al. Cognitive motor           (收稿日期:2021-04-11;修回日期:2021-08-06)
               interference during dual-task gait in essential tremor[J].                      (本文编辑:张小龙)


           (上接第 1398 页)                                        [70]OH D Y,CHAM J,ZHANG L,et al. Immune toxicities elicted
           [65]SCANVION Q,BÉNÉ J,GAUTIER S,et al. Moderate-to-      by CTLA-4 blockade in cancer patients are associated with early
               severe eosinophilia induced by treatment with immune checkpoint   diversification of the T-cell repertoire[J]. Cancer Res,2017,77
               inhibitors:37  cases  from  a  national  reference  center  for   (6):1322-1330. DOI:10.1158/0008-5472.CAN-16-2324.
               hypereosinophilic syndromes and the French pharmacovigilance   [71]LIBERT C,DEJAGER L. How steroids steer T cells[J].
               database[J]. Oncoimmunology,2020,9(1):1722022.       Cell  Rep,2014,7(4):938-939.  DOI:10.1016/j.
               DOI:10.1080/2162402X.2020.1722022.
                                                                    celrep.2014.04.041.
           [66]CYBULSKA-STOPA B,KAMIZSKA-WINCIOREK G,DYDUCH
                                                               [72]LINSLEY P S,BRADY W,URNES M,et al. CTLA-4 is a second
               G. Immune-related adverse events in a patient with eosinophilic
                                                                    receptor for the B cell activation antigen B7[J]. J Exp Med,
               enteritis treated with immune checkpoint inhibitors (anti-PD-
                                                                    1991,174(3):561-569. DOI:10.1084/jem.174.3.561.
               1)[J]. Melanoma Res,2020,30(6):619-624. DOI:
                                                               [73]XU-MONETTE Z Y,ZHOU J F,YOUNG K H. PD-1 expression
               10.1097/CMR.0000000000000693.
                                                                    and clinical PD-1 blockade in B-cell lymphomas[J]. Blood,
           [67]PENG Z,CHENG S Y,KOU Y,et al. The gut microbiome
                                                                    2018,131(1):68-83. DOI:10.1182/blood-2017-07-740993.
               is  associated  with  clinical  response  to  anti-PD-1/PD-L1
                                                               [74]DAS R,BAR N,FERREIRA M,et al. Early B cell changes
               immunotherapy in gastrointestinal cancer[J]. Cancer Immunol
                                                                    predict autoimmunity following combination immune checkpoint
               Res,2020,8(10):1251-1261. DOI:10.1158/2326-6066.
                                                                    blockade[J]. J Clin Invest,2018,128(2):715-720. DOI:
               CIR-19-1014.
           [68]ROUTY  B,LE  CHATELIER  E,DEROSA  L,et  al.  Gut     10.1172/JCI96798.
               microbiome influences efficacy of PD-1-based immunotherapy   [75]ESFAHANI K,ELKRIEF A,CALABRESE C,et al. Moving
               against epithelial tumors[J]. Science,2018,359(6371):  towards personalized treatments of immune-related adverse
               91-97. DOI:10.1126/science.aan3706.                  events[J]. Nat Rev Clin Oncol,2020,17(8):504-515.
           [69]GOPALAKRISHNAN V,SPENCER C N,NEZI L,et al. Gut       DOI:10.1038/s41571-020-0352-8.
               microbiome modulates response to anti-PD-1 immunotherapy in   (收稿日期:2021-04-13;修回日期:2021-10-27)
               melanoma patients[J]. Science,2018,359(6371):97-103.                            (本文编辑:李婷婷)
   123   124   125   126   127   128   129   130   131   132   133